Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|January 1, 2022
Infantile mediastinal neuroblastoma presenting as an oncologic emergency: usefulness of serum-based MYCN gene amplification analysis for risk stratificationMasaya Suematsu, Shigeki Yagyu, Hajime Hosoi, et al.
Frontiers in Immunology|February 14, 2022
PiggyBac Transposon-Mediated CD19 Chimeric Antigen Receptor-T Cells Derived From CD45RA-Positive Peripheral Blood Mononuclear Cells Possess Potent and Sustained Antileukemic FunctionMasaya Suematsu, Shigeki Yagyu, Nobuyoshi Nagao, et al.
British Journal of Cancer|March 23, 2026
Alectinib boosts anti-tumor efficacy of disialoganglioside 2 chimeric antigen receptor T cells in ALK-mutated neuroblastoma by suppressing programmed death-ligand 1Yuya Sugitatsu, Akimasa Tomida, Masaya Suematsu, et al.
Cancer Immunology, Immunotherapy : CII|October 10, 2022
Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangementMasaya Suematsu, Shigeki Yagyu, Hideki Yoshida, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cellsKohei Mitsuno, Masaya Suematsu, Yuki Naito, et al.
NPJ Parkinson'S Disease|June 27, 2017
Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism?Satoshi Sakaue, Takashi Kasai, Ikuko Mizuta, et al.
Pageof 1